Dr. Venkata Sampath V, Medical Oncologist
Apollo Hospital, Hyderabad
 Doctor's Profile
Speciality
ConsultantÂ
Medical Oncologist
Qualifications & Experience
18 years of experience
MBBS, MD - Radiotherapy, DM - Oncology
Hospital
A prospective multicenter, randomized, double-blind, placebo-controlled, 2-parallel groups, phase 3 study to compare the efficacy and safety of masitinib in combination with FOLFIRI (Irinotecan, 5-fluorouracil, and folinic acid) to placebo in combination with FOLFIRI in second-line treatment of patients with metastatic colorectal cancer
Experience in dealing with:
Haematological malignancies, Lung cancer, Breast cancer, Ovarian cancer, HCC, RCC, Prostate cancer, Gastric cancer, Pancreas cancer, Colon cancer, Cervix cancer, GTN, Uterine cancer, Germ cell tumors, CNS tumors, Head & Neck cancers, Paediatric malignancies, Cancer biology, Biostatistics, Cytogenetics, Stem cell transplantation, Molecular & cell biology, Genomics etc
ABOUT
Dr. Vankamamidi Venkata Sampath is a working and Medical and Radiation Oncologist at Yashoda Hospitals, completed MBBS from Kamineni Institute of Medical Sciences, MD (Radiotherapy) from Nizam's Institute of Medical Sciences (NIMS) and DM (Medical Oncology) from Sri Venkateswara Institute of Medical Sciences, SVIMS.
Having following clinical research experience:
Phase III, Inoperable Gastric Cancer, Sub-Investigator, SVIMS/2011
Completed 20 Case Studies at time of MD & DM in NIMS & SVIMS
A Prospective, multicenter, randomised, double-blinded, 2-parallel groups, phase 3 study to compare as first-line therapy efficacy and safety of masitinib in combination with gemcitabine, to gemcitabine in combination with placebo, followed by second line treatment by masitinib in combination with FOLFIRI 3 versus placebo in combination with FOLFIRI 3 in the treatment of patients with nonresectable locally advanced or metastatic pancreatic cancer.